Claudia Mason, MD

Appointed
2008

Education & Fellowships

Residency - University of Missouri-Kansas City School of Medicine
Obstetrics/Gynecology
Kansas City, MO USA
1983

Medical Education - Universidad de Zaragoza
Zaragoza,
1979

Undergraduate - City College of New York
New York, NY USA
1973

Additional Training

• University of Texas Dallas 2001 Master of Science in Medical Management
• North American Menopause Society, Certified Menopause Practitioner 2015

Professional Highlights

• Private Practice OB GYN Stillwater Oklahoma 1983-2005
• Presbyterian Healthcare, Medical Director Espanola Hospital 2005-2007, Staff OB GYN 2005-2008
• Cleveland Clinic Florida 2008 - Present Ambulatory Gynecology
• Regional Quality Officer Cleveland Clinic Florida 2014-present
• Women's Professional Staff Association Florida Representative 2017-2019

Certifications

• Obstetrics and Gynecology

Specialty Interests

Well woman care, contraception, evaluation and treatment of abnormal paps, HPV, abnormal uterine bleeding, humanitarian medicine, menopause and hormone therapy,diagnostic and operative hysteroscopy, vaginitis, vulvar disease, PMS

Awards & Honors

• Physician of the Year for Quality and Patient Safety 2015 Cleveland Clinic Florida
• American Women's Medical Association 2016 Local Hero Award

Innovations & Patents

• " skinny pap" collection

Memberships

• American College Obstetrics and Gynecology
• American Society for Colposcopy and Cervical Pathology
• North American Menopause Society
• American Medical Association
• Women's Professional Staff Association Cleveland Clinic

See publications for Claudia Mason, MD.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 2/15/2023, Dr. Mason has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.